Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity

ZT Morrow, ZM Powers, JD Sauer - Current clinical microbiology reports, 2019 - Springer
Abstract Purpose of Review Immunotherapy has emerged as a promising cancer treatment;
however, success in only select clinical indications underscores the need for novel …
被引用次数：19 相关文章

Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.

ZT Morrow, ZM Powers, JD Sauer - Current Clinical Microbiology …, 2019 - europepmc.org
Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity

ZT Morrow, ZM Powers… - Current clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose of the review Immunotherapy has emerged as a promising cancer treatment,
however success in only select clinical indications underscores the need for novel …
[HTML] nih.gov

[HTML][HTML] Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity

ZT Morrow, ZM Powers, JD Sauer - Current clinical microbiology …, 2019 - ncbi.nlm.nih.gov
Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity.

ZT Morrow, ZM Powers, JD Sauer - Current Clinical Microbiology …, 2019 - europepmc.org
Listeria monocytogenes cancer vaccines: bridging innate and adaptive immunity. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …